Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 4, 2024The company will present clinical evidence in young children, pregnancy and type 2 diabetes*
Medtronic plc, the global leader in medical technology, announced it will present new data on its MiniMed™ 780G system at the upcoming European Association for the Study of Diabetes (EASD) 60th...
-
Aug 7, 2024Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for its Simplera™ continuous glucose monitor (CGM) —...
-
Jun 21, 2024With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn phenomenon, and improved overnight sleep
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the American Diabetes Association's (ADA) 84th Scientific Sessions that...
-
Jun 4, 2024Dr. Petrovski’s expertise will further strengthen Medtronic clinical and scientific activities to help people with diabetes live better with technology
Medtronic, a global leader in healthcare technology, today announced that Dr. Goran Petrovski M.D., Ph.D. has joined the company’s Diabetes Operating Unit as Medical Affairs Director. Dr....
-
Jun 3, 2024
Medtronic, a global leader in medical technology, today announced an overview of its upcoming presence at the American Diabetes Association's (ADA) 84th Scientific Sessions. Following the one-year...
-
Apr 30, 2024Study shows the investigational use of the MiniMed™ 780G system improved glycemic control during pregnancy.
Medtronic, a global leader in healthcare technology, today announced the results of the randomized controlled Closed- loop insulin delivery in pregnant women with type 1 diabetes: a randomized...
-
Apr 23, 2024Groundbreaking studies in Europe and Singapore demonstrate the Medtronic MiniMed™ 780G system can generate cost-savings for health systems.
Medtronic, a global leader in healthcare technology, shared results from separate studies highlighting that the Medtronic MiniMed™ 780G system is a cost-effective therapy option for people...
-
Feb 22, 2024Medtronic will unveil the MiniMed™ 780G system with Simplera Sync™, a new disposable, all-in-one sensor.*
Medtronic plc, the global leader in medical technology, announced the unveiling of new data on its MiniMed™ 780G system at the upcoming 17th International Conference on Advanced Technologies and...
-
Jan 31, 2024
Actress, writer and producer Alexandra Park, best known for her role on The Royals and Australian series Home and Away, is partnering with Medtronic Diabetes to help others living with type 1...
-
Jan 8, 2024With CE Mark approval, the benefits of the MiniMed™ 780G system are now available with a new sensor that takes less than 10 seconds to insert1
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced CE (Conformité Européenne) Mark approval for the MiniMed™ 780G system with Simplera Sync™, a disposable,...
